Literature DB >> 22641000

The role of Klotho in energy metabolism.

M Shawkat Razzaque1.   

Abstract

A disproportionate expansion of white adipose tissue and abnormal recruitment of adipogenic precursor cells can not only lead to obesity but also impair glucose metabolism, which are both common causes of insulin resistance and diabetes mellitus. The development of novel and effective therapeutic strategies to slow the progression of obesity, diabetes mellitus and their associated complications will require improved understanding of adipogenesis and glucose metabolism. Klotho might have a role in adipocyte maturation and systemic glucose metabolism. Klotho increases adipocyte differentiation in vitro, and mice that lack Klotho activity are lean owing to reduced white adipose tissue accumulation; moreover, mice that lack the Kl gene (which encodes Klotho) are resistant to obesity induced by a high-fat diet. Knockout of Kl in leptin-deficient Lep(ob/ob) mice reduces obesity and increases insulin sensitivity, which lowers blood glucose levels. Energy metabolism might also be influenced by Klotho. However, further studies are needed to explore the possibility that Klotho could be a novel therapeutic target to reduce obesity and related complications, and to determine whether and how Klotho might influence the regulation and function of a related protein, β-Klotho, which is also involved in energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641000      PMCID: PMC3704949          DOI: 10.1038/nrendo.2012.75

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  139 in total

Review 1.  FGFs and metabolism.

Authors:  Alexei Kharitonenkov
Journal:  Curr Opin Pharmacol       Date:  2009-08-14       Impact factor: 5.547

2.  A potential regulatory single nucleotide polymorphism in the promoter of the Klotho gene may be associated with essential hypertension in the Chinese Han population.

Authors:  Hu-Lin Wang; Qiang Xu; Zhang Wang; Yi-Hua Zhang; Liang-Yi Si; Xue-Jun Li; Qi-Hong Yang; Hang Xiao
Journal:  Clin Chim Acta       Date:  2009-12-11       Impact factor: 3.786

3.  Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.

Authors:  Regina Goetz; Yuji Nakada; Ming Chang Hu; Hiroshi Kurosu; Lei Wang; Teruyo Nakatani; Mingjun Shi; Anna V Eliseenkova; Mohammed S Razzaque; Orson W Moe; Makoto Kuro-o; Moosa Mohammadi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

4.  Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.

Authors:  Yeong Sook Yoon; Hye Soon Park; Kyung Eun Yun; Soon Bae Kim
Journal:  Metabolism       Date:  2009-07-16       Impact factor: 8.694

5.  Evidence against a direct role of klotho in insulin resistance.

Authors:  Olivier Lorenzi; Christelle Veyrat-Durebex; Claes B Wollheim; Pascal Villemin; Françoise Rohner-Jeanrenaud; Anne Zanchi; Ulrich M Vischer; Ulrich Vischer
Journal:  Pflugers Arch       Date:  2009-09-13       Impact factor: 3.657

6.  Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.

Authors:  Teruyo Nakatani; Mutsuko Ohnishi; M Shawkat Razzaque
Journal:  FASEB J       Date:  2009-07-07       Impact factor: 5.191

7.  Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.

Authors:  I Wolf; Y Laitman; T Rubinek; L Abramovitz; I Novikov; R Beeri; M Kuro-O; H P Koeffler; R Catane; L S Freedman; E Levy-Lahad; B Y Karlan; E Friedman; B Kaufman
Journal:  Oncogene       Date:  2009-10-05       Impact factor: 9.867

8.  Klotho variants and chronic hemodialysis mortality.

Authors:  David J Friedman; Maryam Afkarian; Hector Tamez; Ishir Bhan; Tamara Isakova; Myles Wolf; Elizabeth Ankers; Jun Ye; Marcello Tonelli; Carmine Zoccali; Makoto Kuro-o; Orson Moe; S Ananth Karumanchi; Ravi Thadhani
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

Review 9.  PPARs: diverse regulators in energy metabolism and metabolic diseases.

Authors:  Yong-Xu Wang
Journal:  Cell Res       Date:  2010-01-26       Impact factor: 25.617

10.  In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels.

Authors:  Mutsuko Ohnishi; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque
Journal:  Circ Cardiovasc Genet       Date:  2009-09-21
View more
  37 in total

Review 1.  Klotho: An Elephant in Aging Research.

Authors:  Amin Cheikhi; Aaron Barchowsky; Amrita Sahu; Sunita N Shinde; Abish Pius; Zachary J Clemens; Hua Li; Charles A Kennedy; Joerg D Hoeck; Michael Franti; Fabrisia Ambrosio
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-06-18       Impact factor: 6.053

2.  Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity?

Authors:  Mor-Li Hartman; Francisco Groppo; Mutsuko Ohnishi; J Max Goodson; Hatice Hasturk; Mary Tavares; Tina Yaskell; Constantino Floros; Kazem Behbehani; Mohammed S Razzaque
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

3.  The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.

Authors:  Jezid Miranda; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Tamara Stampalija; Lami Yeo; Zhong Dong; Sonia S Hassan; George P Chrousos; Philip Gold; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-19

4.  Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?

Authors:  Sofiya Bedo Latifyan; Michel Vanhaeverbeek; Jean Klastersky
Journal:  BMJ Case Rep       Date:  2014-11-17

Review 5.  Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.

Authors:  Shunsuke Yamada; Cecilia M Giachelli
Journal:  Bone       Date:  2016-11-12       Impact factor: 4.398

6.  Inorganic Phosphate Activates the AKT/mTORC1 Pathway and Shortens the Life Span of an α‑Klotho-Deficient Model.

Authors:  Masanobu Kawai; Saori Kinoshita; Keiichi Ozono; Toshimi Michigami
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

Review 7.  Molecular basis of Klotho: from gene to function in aging.

Authors:  Yuechi Xu; Zhongjie Sun
Journal:  Endocr Rev       Date:  2015-02-19       Impact factor: 19.871

8.  Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS.

Authors:  Ella Zeldich; Ci-Di Chen; Emma Boden; Bryce Howat; Jason S Nasse; Dean Zeldich; Anthony G Lambert; Andrea Yuste; Jonathan D Cherry; Rebecca M Mathias; Qicheng Ma; Nelson C Lau; Ann C McKee; Theo Hatzipetros; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2019-06-27       Impact factor: 3.444

9.  βKlotho, a direct target of miR-206, contributes to the growth of hepatoblastoma through augmenting PI3K/Akt/mTOR signaling.

Authors:  Tong Chen; Jianglong Chen; Xiuhao Zhao; Jing Zhou; Qingfeng Sheng; Linlin Zhu; Zhibao Lv
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner.

Authors:  Masanobu Kawai; Saori Kinoshita; Shigeki Shimba; Keiichi Ozono; Toshimi Michigami
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.